- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Defensive Stocks
Global Pharmaceuticals & Biotech Defensive Stocks
UPDATED Jun 29, 2022
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
100 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2M7CChina Medical System Holdings | HK$1.44 | 0.7% | -34.5% | HK$29.8b | HK$2.00 | PE8.4x | E8.0% | 4.7% | ||
| CHSY.FChina Medical System Holdings | HK$1.59 | 0% | n/a | HK$29.8b | HK$2.21 | PE8.4x | E8.0% | 4.7% | ||
| 867China Medical System Holdings | HK$12.50 | 2.8% | -38.9% | HK$30.7b | HK$16.89 | PE8.7x | E8.0% | 4.6% | ||
| 867China Medical System Holdings | HK$12.50 | 2.8% | -38.9% | HK$30.7b | HK$16.89 | PE8.7x | E8.0% | 4.6% | ||
| 867China Medical System Holdings | HK$12.16 | 0% | -40.5% | HK$29.8b | HK$16.89 | PE8.4x | E8.0% | 4.7% | ||
| NOVNNovartis | CHF81.19 | 3.3% | -3.7% | CHF176.3b | CHF90.68 | PE7.6x | E2.7% | 3.6% | ||
| SQURPHARMASquare Pharmaceuticals | ৳218.00 | 1.4% | 1.2% | ৳193.2b | ৳320.40 | PE10.4x | E11.6% | 2.8% | ||
| NOTANovartis | CHF81.20 | 5.7% | 5.7% | CHF176.2b | CHF90.75 | PE7.6x | E2.7% | 3.6% | ||
| NVSE.FNovartis | CHF84.85 | 7.7% | -7.8% | CHF176.3b | CHF94.77 | PE7.6x | E2.7% | 3.6% | ||
| NVSNovartis | CHF84.77 | 4.0% | -7.1% | CHF176.3b | CHF94.68 | PE7.6x | E2.7% | 3.6% | ||
| NOVNEENovartis | CHF81.20 | 3.3% | -5.0% | CHF176.3b | CHF90.70 | PE7.6x | E2.7% | 3.6% | ||
| 600332Guangzhou Baiyunshan Pharmaceutical Holdings | HK$31.23 | 1.8% | -7.7% | HK$56.4b | HK$31.74 | PE8.2x | E8.9% | 3.5% | ||
| GU5Guangzhou Baiyunshan Pharmaceutical Holdings | HK$2.68 | 3.1% | 6.3% | HK$55.4b | HK$2.76 | PE8.1x | E8.9% | 3.5% | ||
| 999China Resources Sanjiu Medical & Pharmaceutical | CNÂ¥43.44 | -2.4% | 62.4% | CNÂ¥42.9b | CNÂ¥49.17 | PE19.1x | E13.2% | 2.0% | ||
| 2287Tibet Cheezheng Tibetan Medicine | CNÂ¥26.06 | -1.1% | -3.4% | CNÂ¥13.8b | n/a | PE19.7x | n/a | 2.3% | ||
| 15303SBio | HK$6.45 | 0.9% | -32.8% | HK$15.7b | HK$8.34 | PE8.1x | E6.9% | 3.1% | ||
| IPNIpsen | €89.35 | 4.7% | 1.9% | €7.4b | €102.50 | PE11.4x | E0.7% | 1.3% | ||
| 83B3SBio | HK$0.77 | 4.1% | -24.3% | HK$15.7b | n/a | PE8.1x | E6.9% | 3.1% | ||
| I7GIpsen | €85.50 | 4.7% | -2.5% | €7.0b | €102.74 | PE10.9x | E0.7% | 1.4% | ||
| NVS NNovartis | CHF1,639.26 | 0% | -9.9% | CHF176.3b | CHF1,830.91 | PE7.6x | E2.7% | 3.6% | ||
| 15303SBio | HK$6.66 | 4.2% | -30.6% | HK$16.2b | HK$8.34 | PE8.4x | E6.9% | 3.0% | ||
| NVSNovartis | CHF5,345.00 | 9.1% | 36.2% | CHF176.3b | CHF5,970.05 | PE7.6x | E2.7% | 3.6% | ||
| 999China Resources Sanjiu Medical & Pharmaceutical | CNÂ¥45.00 | 1.4% | 60.1% | CNÂ¥43.0b | CNÂ¥49.17 | PE19.8x | E13.2% | 1.9% | ||
| 2287Tibet Cheezheng Tibetan Medicine | CNÂ¥25.75 | -1.3% | -9.4% | CNÂ¥13.5b | n/a | PE19.4x | n/a | 2.3% |